XML 35 R22.htm IDEA: XBRL DOCUMENT
v3.26.1

Segments of Business | 6 Months Ended
--- | ---
Jun. 28, 2026
Segment Reporting [Abstract] |
Segments of Business | Segments of Business The Company is organized into three reportable business segments: Self Care, Skin Health and Beauty, and Essential Health. The Company’s Chief Operating Decision Maker (the “CODM”), the Chief Executive Officer, uses Segment adjusted operating income as the measure of profit or loss and to evaluate the performance of the Company’s segments. For each segment, the CODM uses this information to assist in evaluating underlying trends, to monitor budget and forecast versus actual results, to make investment decisions to allocate resources both in total, and between the segments, and to make key segment personnel decisions. Segment profit is based on Operating income, excluding depreciation, amortization of intangible assets, Separation-related costs, restructuring expenses and operating model optimization initiatives, the impact of the conversion of stock-based awards, issuance of Founder Shares (as defined below), Pending Transaction and other related costs (as defined below), Skillman sale-leaseback, Other operating expense, net, and unallocated general corporate administrative expenses (referred to herein as “Segment adjusted operating income”), as the CODM excludes these items in assessing segment financial performance. General corporate/unallocated expenses, which include expenses related to treasury, legal operations, and certain other expenses, along with gains and losses related to the overall management of the Company, are not allocated to the segments. In assessing segment performance and managing operations, the CODM does not review segment assets. The Company operates the business through the following three reportable business segments based on product categories:
Reportable Segments | Product Categories
Self Care | Cough, Cold, and Allergy
| Pain Care
| Other Self Care (Digestive Health, Smoking Cessation, Eye Care, and Other)
Skin Health and Beauty | Face and Body Care
| Hair, Sun, and Other
Essential Health | Oral Care
| Baby Care
| Other Essential Health (Women’s Health, Wound Care, and Other)
The Company’s product categories as a percentage of Net sales for the fiscal three and six months ended June 28, 2026 and June 29, 2025 were as follows:
|  | Fiscal Three Months Ended |  | Fiscal Six Months Ended
Product Categories |  | June 28, 2026 |  | June 29, 2025 |  | June 28, 2026 |  | June 29, 2025 |  |
Cough, Cold, and Allergy |  | 12 | % |  | 12 | % |  | 14 | % |  | 14 | % |  |
Pain Care |  | 11 |  |  | 12 |  |  | 12 |  |  | 12 |  |  |
Other Self Care |  | 17 |  |  | 17 |  |  | 16 |  |  | 16 |  |  |
Face and Body Care |  | 18 |  |  | 18 |  |  | 18 |  |  | 18 |  |  |
Hair, Sun, and Other |  | 10 |  |  | 9 |  |  | 10 |  |  | 9 |  |  |
Oral Care |  | 10 |  |  | 11 |  |  | 10 |  |  | 11 |  |  |
Baby Care |  | 10 |  |  | 9 |  |  | 9 |  |  | 9 |  |  |
Other Essential Health |  | 12 |  |  | 12 |  |  | 11 |  |  | 11 |  |  |
Total |  | 100 | % |  | 100 | % |  | 100 | % |  | 100 | % |  |
Segment Net Sales and Segment Adjusted Operating Income Segment net sales and Segment adjusted operating income for the fiscal three and six months ended June 28, 2026 and June 29, 2025 were as follows:
|  | Fiscal Three Months Ended |  |
|  | June 28, 2026 |  | June 29, 2025 |  |
(Dollars in Millions) |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  |  |  |
Net sales |  | $ | 1,589 |  |  | $ | 1,113 |  |  | $ | 1,253 |  |  | $ | 3,955 |  |  | $ | 1,555 |  |  | $ | 1,059 |  |  | $ | 1,225 |  |  | $ | 3,839 |  |  |  |  |
Segment adjusted Cost of sales(1) |  | 550 |  |  | 450 |  |  | 574 |  |  | 1,574 |  |  | 548 |  |  | 422 |  |  | 531 |  |  | 1,501 |  |  |  |  |
Other segment expense items(2) |  | 527 |  |  | 477 |  |  | 364 |  |  | 1,368 |  |  | 480 |  |  | 488 |  |  | 343 |  |  | 1,311 |  |  |  |  |
Segment adjusted operating income |  | $ | 512 |  |  | $ | 186 |  |  | $ | 315 |  |  | $ | 1,013 |  |  | $ | 527 |  |  | $ | 149 |  |  | $ | 351 |  |  | $ | 1,027 |  |  |  |  |
Reconciliation to Income before taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Less: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation(3) |  |  |  |  |  |  |  | 79 |  |  |  |  |  |  |  |  | 78 |  |  |  |  |
Amortization of intangible assets(4) |  |  |  |  |  |  |  | 64 |  |  |  |  |  |  |  |  | 64 |  |  |  |  |
Separation-related costs(5) |  |  |  |  |  |  |  | 7 |  |  |  |  |  |  |  |  | 24 |  |  |  |  |
Restructuring expenses and operating model optimization initiatives(6) |  |  |  |  |  |  |  | 69 |  |  |  |  |  |  |  |  | 68 |  |  |  |  |
Conversion of stock-based awards(7) |  |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  | 1 |  |  |  |  |
Founder Shares(8) |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  | 5 |  |  |  |  |
Pending Transaction and other related costs(9) |  |  |  |  |  |  |  | 16 |  |  |  |  |  |  |  |  | — |  |  |  |  |
Skillman sale-leaseback |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |  | — |  |  |  |  |
Other operating expense, net |  |  |  |  |  |  |  | 6 |  |  |  |  |  |  |  |  | 5 |  |  |  |  |
General corporate/unallocated expenses |  |  |  |  |  |  |  | 70 |  |  |  |  |  |  |  |  | 90 |  |  |  |  |
Operating income |  |  |  |  |  |  |  | $ | 699 |  |  |  |  |  |  |  |  | $ | 692 |  |  |  |  |
Other expense, net |  |  |  |  |  |  |  | 11 |  |  |  |  |  |  |  |  | 10 |  |  |  |  |
Interest expense, net |  |  |  |  |  |  |  | 90 |  |  |  |  |  |  |  |  | 94 |  |  |  |  |
Income before taxes |  |  |  |  |  |  |  | $ | 598 |  |  |  |  |  |  |  |  | $ | 588 |  |  |  |  |
|  | Fiscal Six Months Ended |  |
|  | June 28, 2026 |  | June 29, 2025 |  |  |  |
(Dollars in Millions) |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  |  |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 3,288 |  |  | $ | 2,172 |  |  | $ | 2,404 |  |  | $ | 7,864 |  |  | $ | 3,222 |  |  | $ | 2,036 |  |  | $ | 2,322 |  |  | $ | 7,580 |  |  |  |  |  |  |  |  |  |  |  |  |
Segment adjusted Cost of sales(1) |  | 1,128 |  |  | 887 |  |  | 1,092 |  |  | 3,107 |  |  | 1,135 |  |  | 835 |  |  | 1,027 |  |  | 2,997 |  |  |  |  |  |  |  |  |  |  |  |  |
Other segment expense items(2) |  | 1,023 |  |  | 931 |  |  | 698 |  |  | 2,652 |  |  | 994 |  |  | 960 |  |  | 705 |  |  | 2,659 |  |  |  |  |  |  |  |  |  |  |  |  |
Segment adjusted operating income |  | $ | 1,137 |  |  | $ | 354 |  |  | $ | 614 |  |  | $ | 2,105 |  |  | $ | 1,093 |  |  | $ | 241 |  |  | $ | 590 |  |  | $ | 1,924 |  |  |  |  |  |  |  |  |  |  |  |  |
Reconciliation to Income before taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Less: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation(3) |  |  |  |  |  |  |  | 157 |  |  |  |  |  |  |  |  | 151 |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of intangible assets(4) |  |  |  |  |  |  |  | 129 |  |  |  |  |  |  |  |  | 127 |  |  |  |  |  |  |  |  |  |  |  |  |
Separation-related costs(5) |  |  |  |  |  |  |  | 10 |  |  |  |  |  |  |  |  | 62 |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring expenses and operating model optimization initiatives(6) |  |  |  |  |  |  |  | 147 |  |  |  |  |  |  |  |  | 135 |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of stock-based awards(7) |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  | 4 |  |  |  |  |  |  |  |  |  |  |  |  |
Founder Shares(8) |  |  |  |  |  |  |  | 3 |  |  |  |  |  |  |  |  | 8 |  |  |  |  |  |  |  |  |  |  |  |  |
Pending Transaction and other related costs(9) |  |  |  |  |  |  |  | 32 |  |  |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |
Skillman sale-leaseback |  |  |  |  |  |  |  | 4 |  |  |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |
Other operating expense, net |  |  |  |  |  |  |  | 17 |  |  |  |  |  |  |  |  | 18 |  |  |  |  |  |  |  |  |  |  |  |  |
General corporate/unallocated expenses |  |  |  |  |  |  |  | 139 |  |  |  |  |  |  |  |  | 169 |  |  |  |  |  |  |  |  |  |  |  |  |
Operating income |  |  |  |  |  |  |  | $ | 1,466 |  |  |  |  |  |  |  |  | $ | 1,250 |  |  |  |  |  |  |  |  |  |  |  |  |
Other expense, net |  |  |  |  |  |  |  | 11 |  |  |  |  |  |  |  |  | 16 |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  |  |  |  |  |  | 185 |  |  |  |  |  |  |  |  | 188 |  |  |  |  |  |  |  |  |  |  |  |  |
Income before taxes |  |  |  |  |  |  |  | $ | 1,270 |  |  |  |  |  |  |  |  | $ | 1,046 |  |  |  |  |  |  |  |  |  |  |  |  |
(1) The Company defines Segment adjusted cost of sales as Cost of sales adjusted for amortization of intangible assets, operating model optimization initiatives, Separation-related costs, Pending Transaction and other related costs (as defined below), Founder Shares (as defined below), conversion of stock-based awards, and general corporate/unallocated expenses. (2) Other segment expense items for each reportable business segment include brand support, employee-related costs, shipping and handling costs, research and development costs, and certain other operating expenses (income). (3) Depreciation consists of depreciation of property, plant, and equipment and amortization of integration and development costs capitalized in connection with cloud computing arrangements. (4) Relates to the amortization of definite-lived intangible assets (primarily trademarks, trade names, and customer lists) over their estimated useful lives. (5) See Note 1, “Description of the Company and Summary of Significant Accounting Policies—Separation-Related Costs,” for additional information regarding Separation-related costs. (6) Restructuring expenses and operating model optimization initiatives relate to the 2026 Restructuring Initiative for the fiscal three and six months ended June 28, 2026 and the 2024 Multi-Year Restructuring Initiative for the fiscal three and six months ended June 29, 2025. See Note 15, “Restructuring Expenses and Operating Model Optimization Initiatives,” for additional information. Restructuring expenses and operating model optimization initiatives include accelerated depreciation expense on assets related to the 2026 Restructuring Initiative for the fiscal three and six months ended June 28, 2026. (7) Segment adjusted operating income excludes the impact of the conversion of stock-based awards that occurred on August 23, 2023. The adjustment represents the net impact of the gain on reversal of previously recognized stock-based compensation expense, offset by stock-based compensation expense recognized in the fiscal three and six months ended June 28, 2026 and June 29, 2025 relating to employee services provided prior to the Separation. (8) On August 25, 2023, the Company’s Compensation & Human Capital Committee approved equity grants to individuals employed by Kenvue as of October 2, 2023 (the “Founder Shares”). On October 2, 2023, the Founder Shares were granted to all Kenvue employees in the form of stock options and performance stock units to executive officers and either stock options and performance stock units or restricted stock units to non-executive individuals. (9) Pending Transaction and other related costs consist of expenses incurred in connection with the Pending Transaction, including advisory fees, legal costs, professional service costs, and other related costs (the “Pending Transaction and other related costs”). Depreciation and Amortization Depreciation and amortization by reportable business segment for the fiscal three and six months ended June 28, 2026 and June 29, 2025 were as follows:
|  | Fiscal Three Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Fiscal Six Months Ended
(Dollars in Millions) |  | June 28, 2026 |  | June 29, 2025 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | June 28, 2026 |  | June 29, 2025 |  |
Self Care |  | $ | 52 |  |  | $ | 53 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 105 |  |  | $ | 102 |  |  |
Skin Health and Beauty |  | 32 |  |  | 33 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 62 |  |  | 62 |  |  |
Essential Health |  | 59 |  |  | 56 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 119 |  |  | 114 |  |  |
Total depreciation and amortization(1) |  | $ | 143 |  |  | $ | 142 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 286 |  |  | $ | 278 |  |  |
(1) Depreciation consists of depreciation of property, plant, and equipment and amortization of integration and development costs capitalized in connection with cloud computing arrangements. Amortization relates to the amortization of definite-lived intangible assets over their estimated useful lives.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for segment reporting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 18: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 19: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 20: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 21: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 22: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration